Skip to main content

Animations

MJFF Publications

5841 - 5850 of 8808 Results
Title
Year
  • Year
  • 2024
  • 2005
  • 2024
  • 2008
  • 2022
  • 2017
  • 2025
  • 2017
  • 2023
  • 2019
  • Summary Details
    OPEN
    Title: A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.jbc.2024.107469
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Parkin-deficient mice are not a robust model of parkinsonism
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.0409598102
    Citation Count: 463
  • Summary Details
    OPEN
    Title: Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021
    Journal Name: The Lancet
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/s0140-6736(24)00685-8
    Citation Count: 296
  • Summary Details
    RESTRICTED
    Title: Allosteric modulation of mGluR4 as a novel therapeutic direction for the treatment of Parkinson's disease
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1096/fasebj.22.1_supplement.103.2
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Association of Sodium–Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population-Based Cohort Study
    Journal Name: Diabetes Care
    Publisher: American Diabetes Association
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2337/dc22-1705
    Citation Count: 92
  • Summary Details
    OPEN
    Title: Development of a Positron Emission Tomography Radiotracer for Imaging Elevated Levels of Superoxide in Neuroinflammation
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00385
    Citation Count: 74
  • Summary Details
    RESTRICTED
    Title: Gene therapy device-based delivery of progranulin, prosaposin, and GDNF as a combined precision and neurorestorative therapy in the rat 6-OHDA model of parkinsonism
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2025.115474
    Citation Count: 0
  • Summary Details
    OPEN
    Title: DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0175424
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Episodic memory deficit in HIV infection: common phenotype with Parkinson’s disease, different neural substrates
    Journal Name: Brain Structure and Function
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00429-023-02626-x
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Bidirectional dopamine modulation of excitatory and inhibitory synaptic inputs to subthalamic neuron subsets containing α4β2 or α7 nAChRs
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2019.01.015
    Citation Count: 14
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.